IP Library Granted Patent US 8,027,738
Granted Patent B2
US 8,027,738 · App. 11/424,115 · Granted Sep 27, 2011

Probe for treating a tumor or the like

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,027,738
App. No.
11/424,115
Granted
Sep 27, 2011
Kind
B2
Abstract

An article of clothing is provided for selectively destroying dividing cells in living tissue formed of dividing cells and non-dividing cells. The dividing cells contain polarizable intracellular members and during late anaphase or telophase, the dividing cells are connected to one another by a cleavage furrow. The article of clothing includes insulated electrodes to be coupled to a generator for subjecting the living tissue to electric field conditions sufficient to cause movement of the polarizable intracellular members toward the cleavage furrow in response to a non-homogeneous electric field being induced in the dividing cells. The non-homogeneous electric field produces an increased density electric field in the region of the cleavage furrow. The movement of the polarizable intracellular members towards the cleavage furrow causes the breakdown thereof which adversely impacts the multiplication of the dividing cells.

Claims (9)

1. A probe for treatment of a section of living tissue by selectively destroying dividing cells of a target section of tissue, the dividing cells having polarizable or polar intracellular members, the probe comprising:

a probe body for insertion into a body;

at least two electrodes disposed at an outer surface of the probe body, wherein each of the electrodes includes a conductor disposed beneath an insulating outer layer; and

an electric field source for applying an alternating electric potential across the conductors of the at least two insulated electrodes, wherein the alternating electric potential and the electrodes are configured to operate together to impose, in the target section, an electric field with frequency and amplitude characteristics such that application of the electric field to the target section encourages the destruction of dividing cells located in the target section but leaves non-dividing cells located in the target section unharmed, and wherein the destruction of dividing cells is accomplished by disrupting cleavage furrows of the dividing cells during the cell division process, wherein the electric field that is applied to the target section has a field strength between 0.1 and 10 V/cm.

2. The probe of claim 1 , wherein the electric field source comprises a generator that generates an alternating voltage waveform at frequencies between about 100 KHz to about 300 KHz.

3. A method for treatment of a section of living tissue by selectively destroying dividing cells of a target section of tissue, the dividing cells having polarizable or polar intracellular members, the method comprising:

positioning a probe in the vicinity of the target section, the probe having a body and at least two electrodes disposed at an outer surface of the probe body, wherein each of the electrodes includes a conductor disposed beneath an insulating outer layer; and

applying an alternating electric potential across the conductors of the at least two insulated electrodes, so as to impose, in the target section, an electric field with frequency and amplitude characteristics such that application of the electric field to the target section encourages the destruction of dividing cells located in the target section but leaves non-dividing cells located in the target section unharmed, and wherein the destruction of dividing cells is accomplished by disrupting cleavage furrows of the dividing cells during the cell division process, wherein the electric field that is applied to the target section has a field strength between 0.1 and 10 V/cm.

4. The method of claim 3 , wherein the electric potential has a frequency between about 100 KHz to about 300 KHz.

Assignments (18)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
CHANGE OF NAME Recorded Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034548/0231 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
SECURITY AGREEMENT Recorded Feb 20, 2013
From: NOVOCURE LIMITED
To: DEUTSCHE BANK TRUST COMPANY AMERICAS
Reel/Frame 029845/0135 →